Drug evaluation: the C5a receptor antagonist PMX-53
Köhl, J.ör.
Current Opinion in Molecular Therapeutics 8(6): 529-538
2006
ISSN/ISBN: 1464-8431 PMID: 17243489 Document Number: 600411
Peptech is developing PMX-53, a complement C5a inhibitor for the potential treatment of inflammatory disorders, including rheumatoid arthritis and psoriasis. Phase Ib/IIa clinical trials have been completed for both indications.
Document emailed within 1 workday
Related Documents
Gabay, C.; Porter, B.; Fantuzzi, G.; Arend, W.P. 1998: Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo Journal of Immunology 159(12): 5905-5913Ennis, C.; Cox, B. 1980: The dopamine receptor antagonist domperidone is also a competitive antagonist at alpha 1-adrenoceptors Journal of Pharmacy and Pharmacology 32(6): 434-435
Iijima, Y.; Asami, T.; Kuribara, H. 1996: Modification by MK-801 (dizocilpine), a noncompetitive NMDA receptor antagonist, of morphine sensitization: evaluation by ambulation in mice Nihon Shinkei Seishin Yakurigaku Zasshi 16(1): 11-18
Regidor, P.A.; Nelken, B.; Regidor, M.; Bier, U.; Oberhoff, C.; Schindler, A.E. 1996: Effectiveness and tolerance of Navoban (5HT3-receptor antagonist tropisetron) in prevention of cytostatic drug-induced nausea and vomiting in patients with breast carcinomas and gynecological malignancies Zentralblatt für Gynakologie 118(3): 148-153
Tsuchida, T.; Matsuse, H.; Machida, I.; Kondo, Y.; Saeki, S.; Tomari, S.; Obase, Y.; Matsuo, N.; Shimoda, T.; Kohno, S. 2005: Evaluation of theophylline or pranlukast, a cysteinyl leukotriene receptor 1 antagonist, as add-on therapy in uncontrolled asthmatic patients with a medium dose of inhaled corticosteroids Allergy and Asthma Proceedings 26(4): 287-291
Habu, Y.; Yoshino, T.; Shio, S.; Hayakumo, T.; Kawai, K. 2004: Evaluation of the efficacy and the cost-effectiveness of maintenance treatment of gastroesophageal reflux disease: proton pump inhibitor versus histamine-2-receptor antagonist Nihon Rinsho. Japanese Journal of Clinical Medicine 62(8): 1504-1509
Liu, G.; Liu, Z.; Song, Y.; Yu, R. 2000: Quantitative evaluation of dyspnea and the effects of M-receptor antagonist on dyspnea in patients with chronic obstructive pulmonary disease Zhonghua Nei Ke Za Zhi 39(12): 828-830
Hayashi, H.; Onozaki, K. 2010: Interleukin-1(IL-1) alpha, beta, IL-1 receptor (IL-1R), IL-1 receptor antagonist (IL-1ra) Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 7): 62-66
Hayashi, H.; Onozaki, K. 2005: Interleukin-1 (IL-1) alpha, beta, IL-1 receptor, IL-1 receptor antagonist (IL-1ra) Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 8): 60-64
Spetea, M.; Asim, M.Faheem.; Noha, S.; Wolber, G.; Schmidhammer, H. 2013: Current κ opioid receptor ligands and discovery of a new molecular scaffold as a κ opioid receptor antagonist using pharmacophore-based virtual screening Current Pharmaceutical Design 19(42): 7362-7372
Hwang, S.B.; Lam, M.H.; Hsu, A.H. 1989: Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors Molecular Pharmacology 35(1): 48-58
Kamada, T.; Kusunoki, H.; Manabe, N.; Shiotani, A.; Hata, J.; Haruma, K. 2007: Histamine-2 receptor antagonist Nihon Rinsho. Japanese Journal of Clinical Medicine 65(10): 1835-1840
Berner, B.D.; Conner, C.S.; Sawyer, D.R.; Siepler, J.K. 1983: Ranitidine: a new H2-receptor antagonist Clinical Pharmacy 1(6): 499-509
Khanna, N. 2001: Flumazenil is a benzodiazepine receptor antagonist Indian Journal of Physiology and Pharmacology 45(3): 386
DiPalma, J.R. 1990: Metoclopramide: a dopamine receptor antagonist American Family Physician 41(3): 919-924
Amland, P.F.; Svane, S. 1987: H2 receptor antagonist treatment and stomach cancer Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 107(12): 1023
Simons, F.E. 1989: Loratadine, a non-sedating H1-receptor antagonist (antihistamine) Annals of Allergy 63(4): 266-268
Minoguchi, K.; Adachi, M. 2001: Thromboxane A2 synthase inhibitor and receptor antagonist Nihon Rinsho. Japanese Journal of Clinical Medicine 59(10): 1986-1991
Arakawa, K.; Akami, T.; Okamoto, M.; Akioka, K.; Nakai, I.; Oka, T.; Nagase, H. 1993: Immunosuppression by delta opioid receptor antagonist Transplantation Proceedings 25(1 Part 1): 738-740
Klingman, D.; Bielory, L.; Wang, Y.; Silverman, S.; Bell, C.F.; Joy, K.A.; Dever, M.T.; Jones, D.A. 2001: Asthma outcome changes associated with use of the leukotriene-receptor antagonist zafirlukast Managed Care Interface 14(2): 62-66